Matches in Wikidata for { <http://www.wikidata.org/entity/Q61966951> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q61966951 description "clinical trial" @default.
- Q61966951 description "ensayo clínico" @default.
- Q61966951 description "ensayu clínicu" @default.
- Q61966951 description "klinisch onderzoek" @default.
- Q61966951 description "клінічне випробування" @default.
- Q61966951 description "临床试验" @default.
- Q61966951 name "In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease" @default.
- Q61966951 type Item @default.
- Q61966951 label "In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease" @default.
- Q61966951 prefLabel "In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease" @default.
- Q61966951 P1132 Q61966951-EE23B443-51FF-4193-889C-081215BB3FE4 @default.
- Q61966951 P1476 Q61966951-755C4483-A61A-42D3-9AB5-2E110E290920 @default.
- Q61966951 P17 Q61966951-0FBAC6AF-6886-4BCB-AC51-4AA99BB42937 @default.
- Q61966951 P1813 Q61966951-7B2E8A9A-630D-43ED-9119-03F9E2040040 @default.
- Q61966951 P2899 Q61966951-8257E232-683C-44B5-A5E7-65679C96B3E7 @default.
- Q61966951 P3098 Q61966951-3E09DE2B-9A60-4032-A02D-91BF5B79675F @default.
- Q61966951 P31 Q61966951-DAC526D6-DFF2-434E-BCA4-4D79BA723E0D @default.
- Q61966951 P4135 Q61966951-AB4C6C5B-8D43-4EBC-BEB6-B1ACAF09F851 @default.
- Q61966951 P4844 Q61966951-2E629248-3875-4AFE-AE04-B28F9A79269C @default.
- Q61966951 P4844 Q61966951-6B1BA013-037E-4D85-945E-CEFEBD3B59AC @default.
- Q61966951 P4844 Q61966951-82241603-3B81-41D6-B6B0-F1FCA1F63C8E @default.
- Q61966951 P4844 Q61966951-EFE73BFD-6A3D-47FE-832C-F12491628121 @default.
- Q61966951 P580 Q61966951-B39813F3-5DA4-4EBD-AF73-94249E6D49EC @default.
- Q61966951 P582 Q61966951-4F172DFF-461F-4BCE-8231-6635918C1FE2 @default.
- Q61966951 P6099 Q61966951-34F2ED78-C3D9-4437-A94D-C392F3DCD60C @default.
- Q61966951 P6099 Q61966951-35B9F771-6F38-4ED6-BAF1-277CC6AAD6C6 @default.
- Q61966951 P6153 Q61966951-6CDF51A8-514D-42AF-995E-228988F9B245 @default.
- Q61966951 P8005 Q61966951-FD5B94CD-1946-44F0-9223-92404486E81B @default.
- Q61966951 P8363 Q61966951-552A1256-4CDF-4E7A-9F55-E441AB1538CB @default.
- Q61966951 P1132 "+3" @default.
- Q61966951 P1476 "Phase I- II Study of in Vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for the Treatment of Steroid-refractory Acute Graft-versus-host Disease" @default.
- Q61966951 P17 Q30 @default.
- Q61966951 P1813 "T-REG" @default.
- Q61966951 P2899 "+18" @default.
- Q61966951 P3098 "NCT01453140" @default.
- Q61966951 P31 Q30612 @default.
- Q61966951 P4135 "+70" @default.
- Q61966951 P4844 Q32089 @default.
- Q61966951 P4844 Q408524 @default.
- Q61966951 P4844 Q416451 @default.
- Q61966951 P4844 Q421052 @default.
- Q61966951 P580 "2011-08-01T00:00:00Z" @default.
- Q61966951 P582 "2012-03-01T00:00:00Z" @default.
- Q61966951 P6099 Q42824440 @default.
- Q61966951 P6099 Q5452194 @default.
- Q61966951 P6153 Q5637237 @default.
- Q61966951 P8005 Q76651189 @default.
- Q61966951 P8363 Q78089383 @default.